Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyproheptadine with/without Nutritional Supplement in Pediatric Cancer Weight Loss
NCT00949117Phase 2Terminated
- Sponsor
- University of South Florida
- Start
- Sep 2009
- Primary completion
- Nov 2011
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, open-label trial of cyproheptadine in cancer cachexia and Malnutrition (2 arms), sponsored by University of South Florida. Primary endpoint: Difference Between Measures of Weight at Baseline and at Week 24. Started Sep 2009; status: terminated.
02
Drugs
cyproheptadine
03
Conditions
cancer cachexiaMalnutrition
Beyond the preview
Go deeper on NCT00949117.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00949117.